Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?

Berkshire Hathaway plans to resume share repurchases, with new CEO Greg Abel consulting Warren Buffett and signaling the stock is undervalued. Buffett still owns 38.4% of Class A shares and 30.2% of Class B shares, while Abel disclosed a $15 million personal investment in Berkshire. The article is broadly constructive on governance continuity and capital returns, but it is more of a commentary piece than a material operational update.

Analysis

The signal is less about one buyback and more about governance continuity at a moment when Berkshire’s capital allocation problem has become the whole story. When an acquirer with a fortress balance sheet starts shrinking itself, it is implicitly saying the hurdle rate for external deployment is higher than the market assumes; that tends to support the stock multiple even if near-term reported growth stays muted. The second-order effect is that Berkshire is becoming a quasi-closed-end capital return vehicle while waiting for a dislocation, which should reduce the probability of a meaningful de-rating as long as repurchases remain disciplined.

The real catalyst window is months, not days: buybacks plus a large cash hoard create a soft floor under BRK.B relative to the market, but they also cap upside if investors were hoping for a transformative capital deployment event. In the near term, the main risk is that this becomes read as "there is nothing to buy," which could keep the conglomerate in a dead-money state versus higher-beta financials and quality compounders. Conversely, if macro volatility rises, Berkshire’s optionality improves sharply because every incremental drawdown increases the value of waiting and buying back stock at wider discounts.

The market may be underestimating how much personal insider alignment matters here. Abel buying alongside repurchases lowers the perceived agency risk of the transition and gives long-only holders a cleaner narrative: the new regime is not trying to reinvent the machine, just optimize it. That should help BRK.B own a premium vs. other cash-rich holdcos, but the premium likely narrows if repurchases accelerate without a visible pipeline of acquisitions or if insurance underwriting weakens.

The clearest contrarian point is that this is not a bullish call on broad equities; it is a bullish call on Berkshire’s internal compounding machine relative to its own alternatives. If the market keeps rewarding AI/growth beta, BRK.B can lag for extended stretches even while fundamentals remain solid. The trade works best when paired against crowded duration/growth exposure or funded through names where capital return is being mistaken for growth acceleration.

Key Decisions for Investors

• Long BRK.B on a 3-6 month horizon; add on market pullbacks. Risk/reward is favorable if buybacks continue below conservative intrinsic value, with downside buffered by cash and upside coming from multiple support rather than earnings acceleration.
• Pair trade: long BRK.B / short a high-duration mega-cap growth basket (e.g., NVDA via smaller notional or a peer basket) for 1-3 months. Thesis: capital-return discipline and lower valuation risk in BRK.B should outperform if rates stay sticky or risk appetite cools.
• Buy BRK.B call spreads 6-12 months out to express a moderated upside view while capping theta risk. Best used if you expect the market to re-rate Berkshire’s governance transition but do not expect a catalyst-rich quarter.
• Avoid chasing NVDA/INTC/NFLX on this headline alone; the article’s incremental signal is governance/capital allocation, not a change in their fundamentals. Use any broad risk-off reaction to accumulate BRK.B instead of reaching for the AI trade.
• If BRK.B outperforms sharply on the buyback narrative, trim 20-30% into strength: the move is likely to be valuation support, not a new growth leg, so upside can compress once the transition premium is priced in.